Since the Korean Journal of Pediatric Neurosurgery (KJPN) was first issued by the Korean Society for Pediatric Neurosurgery (KSPN) in 2004, KJPN has made efforts to ensure that clinical experiences are shared with updated knowledge and to provide education on pediatric neurosurgery topics. However, as a domestic journal, at times KJPN had difficulty in publishing high impact papers on this topic. Therefore, KSPN decided to discontinue the publication of KJPN and instead to publish an official journal the Pediatric Issue as a supplement to the Journal of Korean Neurosurgical Society (JKNS) in 2014. The Pediatric Issue aims to share updated information on specific topics of pediatric neurosurgery with general neurosurgeons and also those in other subspecialties.
Ever since, JKNS : Pediatric Issue has been published annually from 2015. The topics of the Pediatric Issue so far have been Moyamoya disease (edited by Professor Seung-Ki Kim), Craniosynostosis (invited editor, Professor Joon-Ki Kang) and Neuroendoscopy (invited editor, Professor JoongUhn Choi).
The topic of the Pediatric Issue in 2018 is 'Pediatric malignant brain cancers in the molecular era' and was organized by the invited editor, Professor James T. Rutka, a world-renowned leader of pediatric neuro-oncology (Fig. 1) .
Professor James T. Rutka, born in Toronto, was educated at Princeton University (1975 University ( -1977 , and Queen's University Medical School (1977 School ( -1981 (1984) (1985) (1986) (1987) .
Dr. Rutka assumed his appointment in the Division of Neurosurgery, the Department of Surgery, the University of Toronto in 1990. He is a pediatric neurosurgeon whose clinical practice has been at the Hospital for Sick Children. Dr. Rutka's primary research and clinical interests are related to the science and surgery of human brain tumors and epilepsy. He has achieved over 500 peer reviewed publications.
In Because of his achievements in Pediatric Neurosurgery, Dr. Rutka was invited as the editor of Pediatric Issue of 2018 : Pediatric malignant brain cancers in the molecular era. He has maintained a strong tie with the Korean Neurosurgical Society since 1997 when he was invited as a speaker to the International Symposium on the 10th Anniversary of KSPN (Fig. 2) . At that symposium he delivered three fascinating lectures titled 'Update in neuro-oncological basic research', 'Frameless stereotactic surgery in pediatric neurosurgery', and 'Brain stem tumor'. So far many Korean neurosurgeons have had a privilege of receiving training experience at Dr. Rutka's lab and clinic.
In 2016, the World Health Organization Classification of Tumors of the Central Nervous System underwent major revision with molecular profiling of brain tumours receiving stronger emphasis. Accordingly, integrated diagnosis combining histology and molecular characteristics has been widely recommended for brain tumors, which amounts to a major paradigm shift. Now, further refinement of risk stratification is needed in order to improve patient prognosis, and to constitute the basis for finding therapeutic targets within each tumor entity.
Dr. Rutka is pleased to share these advancements and trends with all members of Korean Neurosurgical Society. Twelve articles were contributed by leading researchers in this field in Korea and Canada; in particular, his colleagues from the Toronto group have actively participated in the major changes that have occurred in our understanding of pediatric malignant brain cancers in the molecular era : Dr. Michael Taylor has written on medulloblastoma, Dr. Annie Huang on atypical teratoid/rhabdoid tumor, Dr. James T. Rutka on diffuse midline glioma, H3 K27M-mutant, and Dr. Uri Tabori on high grade glioma and its genetic basis. Finally, Dr. Rutka has concluded this special issue by sharing his views on the current practice of pediatric neuro-on- 
